SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-298839
Filing Date
2022-12-06
Accepted
2022-12-06 06:36:03
Documents
14
Period of Report
2022-11-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d433348d8k.htm   iXBRL 8-K 32782
2 EX-10.1 d433348dex101.htm EX-10.1 63076
3 EX-99.1 d433348dex991.htm EX-99.1 10009
  Complete submission text file 0001193125-22-298839.txt   252621

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA krtx-20221130.xsd EX-101.SCH 2841
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE krtx-20221130_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krtx-20221130_pre.xml EX-101.PRE 11255
8 EXTRACTED XBRL INSTANCE DOCUMENT d433348d8k_htm.xml XML 3335
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38958 | Film No.: 221446659
SIC: 2834 Pharmaceutical Preparations